The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA.
dc.rights.license | open | en_US |
dc.contributor.author | NKONGOLO, Shirin | |
dc.contributor.author | NUSSBAUM, Lea | |
dc.contributor.author | LEMPP, Florian A | |
hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
dc.contributor.author | WODRICH, Harald | |
dc.contributor.author | URBAN, Stephan | |
dc.contributor.author | NI, Yi | |
dc.date.accessioned | 2023-11-13T13:35:05Z | |
dc.date.available | 2023-11-13T13:35:05Z | |
dc.date.issued | 2019-08-01 | |
dc.identifier.issn | 1872-9096 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/184737 | |
dc.description.abstractEn | Chronic infection with the human Hepatitis B virus (HBV) is a major global health problem. Hepatitis D virus (HDV) is a satellite of HBV that uses HBV envelope proteins for cell egress and entry. Using infection systems encoding the HBV/HDV receptor human sodium taurocholate co-transporting polypeptide (NTCP), we screened 1181 FDA-approved drugs applying markers for interference for HBV and HDV infection. As one primary hit we identified Acitretin, a retinoid, as an inhibitor of HBV replication and HDV release. Based on this, other retinoic acid receptor (RAR) agonists with different specificities were found to interfere with HBV replication, verifying that the retinoic acid receptor pathway regulates replication. Of the eight agonists investigated, RARα-specific agonist Am80 (tamibarotene) was most active. Am80 reduced secretion of HBeAg and HBsAg with ICs 12 days after removal of the drug. HBV genotypes B, D, and E were equally inhibited. By contrast, Am80 did not affect HBV replication in transfected cells or HepG2.2.15 cells, which carry an integrated HBV genome. In conclusion, our results indicate a persistent inhibition of HBV transcription by Am80, which might be used for drug repositioning. | |
dc.language.iso | EN | en_US |
dc.subject.en | Acitretin | |
dc.subject.en | Antiviral Agents | |
dc.subject.en | Benzoates | |
dc.subject.en | Cells | |
dc.subject.en | Cultured | |
dc.subject.en | DNA | |
dc.subject.en | Circular | |
dc.subject.en | DNA | |
dc.subject.en | Viral | |
dc.subject.en | Hepatitis B Surface Antigens | |
dc.subject.en | Hepatitis B e Antigens | |
dc.subject.en | Hepatitis B virus | |
dc.subject.en | Hepatitis Delta Virus | |
dc.subject.en | Hepatocytes | |
dc.subject.en | Humans | |
dc.subject.en | RNA | |
dc.subject.en | Viral | |
dc.subject.en | Receptors | |
dc.subject.en | Retinoic Acid | |
dc.subject.en | Tetrahydronaphthalenes | |
dc.subject.en | Transcription | |
dc.subject.en | Genetic | |
dc.title.en | The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA. | |
dc.title.alternative | Antiviral Res | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1016/j.antiviral.2019.04.009 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Microbiologie et Parasitologie | en_US |
dc.identifier.pubmed | 31018112 | en_US |
bordeaux.journal | Antiviral Research | en_US |
bordeaux.page | 146-155 | en_US |
bordeaux.volume | 168 | en_US |
bordeaux.hal.laboratories | MFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234 | en_US |
bordeaux.institution | CNRS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.import.source | pubmed | |
hal.identifier | hal-04282438 | |
hal.version | 1 | |
hal.date.transferred | 2023-11-13T13:35:08Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
workflow.import.source | pubmed | |
dc.rights.cc | Pas de Licence CC | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Antiviral%20Research&rft.date=2019-08-01&rft.volume=168&rft.spage=146-155&rft.epage=146-155&rft.eissn=1872-9096&rft.issn=1872-9096&rft.au=NKONGOLO,%20Shirin&NUSSBAUM,%20Lea&LEMPP,%20Florian%20A&WODRICH,%20Harald&URBAN,%20Stephan&rft.genre=article |